Skip to main content
Top
Published in: BMC Nephrology 1/2021

Open Access 01-12-2021 | Kidney Transplantation | Case report

Primary hyperoxaluria diagnosed after kidney transplantation: a case report and literature review

Authors: Zhitao Cai, Mao Ding, Rengui Chen, Jiefu Zhu, Lian Li, Xiongfei Wu

Published in: BMC Nephrology | Issue 1/2021

Login to get access

Abstract

Background

Primary hyperoxaluria (PH) is a rare inherited autosomal recessive disease caused by disturbed glyoxylate metabolism. The disease is characterized by calcium oxalate crystal deposition in various organs, especially in the kidney. Due to the lack of current understanding of PH, nearly all patients are only initially diagnosed with PH when recurrent lithiasis and progressive end-stage renal disease occur. Many cases are not diagnosed in patients until renal allograft insufficiency occurs after renal transplantation. This case report and literature review aim to emphasize the need for careful pre-transplant PH screening of patients with bilateral nephrocalcinosis or nephrolithiasis.

Case presentation

Renal allograft insufficiency was diagnosed as PH after kidney transplantation. Here, we detail the complete clinical course, including computed tomography images of the original kidney and renal graft, histopathological images of a biopsy of the transplanted kidney, the results of laboratory and molecular genetic tests, and the treatment. In addition, we reviewed the literature from 2000 to 2021 and analyzed 19 reported cases of PH diagnosed after kidney transplantation, and provide a summary of the characteristics, complications, treatment, and prognosis of these cases.

Conclusions

By reviewing and analyzing these cases, we concluded that patients with a history of nephrocalcinosis or nephrolithiasis in both kidneys need preoperative screening for PH and appropriate treatment before kidney transplantation. Delayed graft function caused by PH is easily misdiagnosed as acute rejection, and needle biopsy should be performed at an early stage.
Appendix
Available only for authorised users
Literature
1.
2.
go back to reference Cochat P, Rumsby G. Primary hyperoxaluria. N Engl J Med. 2013;369(7):649–58.CrossRef Cochat P, Rumsby G. Primary hyperoxaluria. N Engl J Med. 2013;369(7):649–58.CrossRef
3.
go back to reference Hopp K, Cogal AG, Bergstralh EJ, Seide BM, Olson JB, Meek AM, et al. Phenotype-genotype correlations and estimated carrier frequencies of primary hyperoxaluria. J Am Soc Nephrol. 2015;26(10):2559–70.CrossRef Hopp K, Cogal AG, Bergstralh EJ, Seide BM, Olson JB, Meek AM, et al. Phenotype-genotype correlations and estimated carrier frequencies of primary hyperoxaluria. J Am Soc Nephrol. 2015;26(10):2559–70.CrossRef
4.
go back to reference Milliner DS, McGregor TL, Thompson A, Dehmel B, Knight J, Rosskamp R, et al. End points for clinical trials in primary Hyperoxaluria. Clin J Am Soc Nephrol. 2020;15(7):1056–65.CrossRef Milliner DS, McGregor TL, Thompson A, Dehmel B, Knight J, Rosskamp R, et al. End points for clinical trials in primary Hyperoxaluria. Clin J Am Soc Nephrol. 2020;15(7):1056–65.CrossRef
5.
go back to reference Riksen NP, Timmers HJ, Assmann KJ, Huysmans FT, et al. Renal graft failure due to type 1 primary hyperoxaluria. Neth J Med. 2002;60(10):407–10.PubMed Riksen NP, Timmers HJ, Assmann KJ, Huysmans FT, et al. Renal graft failure due to type 1 primary hyperoxaluria. Neth J Med. 2002;60(10):407–10.PubMed
6.
go back to reference Kim HH, Koh HI, Ku BI, Lee HS, et al. Late-onset primary hyperoxaluria diagnosed after renal transplantation presented with early recurrence of disease. Nephrol Dial Transplant. 2005;20(8):1738–40.CrossRef Kim HH, Koh HI, Ku BI, Lee HS, et al. Late-onset primary hyperoxaluria diagnosed after renal transplantation presented with early recurrence of disease. Nephrol Dial Transplant. 2005;20(8):1738–40.CrossRef
7.
go back to reference Zhu X, Zhang J, Zhang L,Xie X, et al. Primary hyperoxaluria leads to renal graft loss. Chin J Organ Transpl. 2005;26(01):13. Zhu X, Zhang J, Zhang L,Xie X, et al. Primary hyperoxaluria leads to renal graft loss. Chin J Organ Transpl. 2005;26(01):13.
8.
go back to reference Madiwale C, Murlidharan P, Hase NK, et al. Recurrence of primary hyperoxaluria: an avoidable catastrophe following kidney transplant. J Postgrad Med. 2008;54(3):206–8.CrossRef Madiwale C, Murlidharan P, Hase NK, et al. Recurrence of primary hyperoxaluria: an avoidable catastrophe following kidney transplant. J Postgrad Med. 2008;54(3):206–8.CrossRef
9.
go back to reference Chen H, Chen J, Liu Z, Li L, et al. Oxalate deposition in renal graft after renal transplantation. Chin J Nephrol Dial Transpl. 2008;01:90–3. Chen H, Chen J, Liu Z, Li L, et al. Oxalate deposition in renal graft after renal transplantation. Chin J Nephrol Dial Transpl. 2008;01:90–3.
10.
go back to reference Celik G, Sen S, Sipahi S, Akkin C, Tamsel S, Toz H, et al. Regressive course of oxalate deposition in primary hyperoxaluria after kidney transplantation. Ren Fail. 2010;32(9):1131–6.CrossRef Celik G, Sen S, Sipahi S, Akkin C, Tamsel S, Toz H, et al. Regressive course of oxalate deposition in primary hyperoxaluria after kidney transplantation. Ren Fail. 2010;32(9):1131–6.CrossRef
11.
go back to reference Spasovski G, Beck BB, Blau N, Hoppe B, Tasic V, et al. Late diagnosis of primary hyperoxaluria after failed kidney transplantation. Int Urol Nephrol. 2010;42(3):825–9.CrossRef Spasovski G, Beck BB, Blau N, Hoppe B, Tasic V, et al. Late diagnosis of primary hyperoxaluria after failed kidney transplantation. Int Urol Nephrol. 2010;42(3):825–9.CrossRef
12.
go back to reference Malakoutian T, Asgari M, Houshmand M, Mohammadi R, Aryani O, Mohammadi PE, et al. Recurrence of primary hyperoxaluria after kidney transplantation. Iran J Kidney Dis. 2011;5(6):429–33.PubMed Malakoutian T, Asgari M, Houshmand M, Mohammadi R, Aryani O, Mohammadi PE, et al. Recurrence of primary hyperoxaluria after kidney transplantation. Iran J Kidney Dis. 2011;5(6):429–33.PubMed
13.
go back to reference Naderi G, Tabassomi F, Latif A, Ganji M, et al. Primary hyperoxaluria type 1 diagnosed after kidney transplantation: the importance of pre-transplantation metabolic screening in recurrent urolithiasis. Saudi J Kidney Dis Transpl. 2015;26(4):783–5.CrossRef Naderi G, Tabassomi F, Latif A, Ganji M, et al. Primary hyperoxaluria type 1 diagnosed after kidney transplantation: the importance of pre-transplantation metabolic screening in recurrent urolithiasis. Saudi J Kidney Dis Transpl. 2015;26(4):783–5.CrossRef
14.
go back to reference Wang X, Fu Y, Liu S, Wu S, Yu J, Gao B, et al. Primary hyperoxaluria leads to renal graft loss after kidney transplantation, et al. a case and literature review. Chin J Lab Diagn. 2016;20(06):1030–1.CrossRef Wang X, Fu Y, Liu S, Wu S, Yu J, Gao B, et al. Primary hyperoxaluria leads to renal graft loss after kidney transplantation, et al. a case and literature review. Chin J Lab Diagn. 2016;20(06):1030–1.CrossRef
15.
go back to reference Rios J, Zuluaga M, Higuita L, Florez A, Bello-Marquez DC, Aristizabal A, et al. Primary hiperoxaluria diagnosed after kidney transplantation: report of 2 cases and literature review. J Bras Nefrol. 2017;39(4):462–6.CrossRef Rios J, Zuluaga M, Higuita L, Florez A, Bello-Marquez DC, Aristizabal A, et al. Primary hiperoxaluria diagnosed after kidney transplantation: report of 2 cases and literature review. J Bras Nefrol. 2017;39(4):462–6.CrossRef
16.
go back to reference Liu S, Gao B, Wang G, Wang W, Lian X, Wu S, et al. Recurrent primary hyperoxaluria type 2 leads to early post-transplant renal function loss: a case report. Exp Ther Med. 2018;15(4):3169–72.PubMedPubMedCentral Liu S, Gao B, Wang G, Wang W, Lian X, Wu S, et al. Recurrent primary hyperoxaluria type 2 leads to early post-transplant renal function loss: a case report. Exp Ther Med. 2018;15(4):3169–72.PubMedPubMedCentral
17.
go back to reference Cai R, Lin M, Chen Z, Lai Y, Huang X, Zhao G, et al. Primary hyperoxaluria diagnosed after kidney transplantation failure: lesson from 3 case reports and literature review. BMC Nephrol. 2019;20(1):224.CrossRef Cai R, Lin M, Chen Z, Lai Y, Huang X, Zhao G, et al. Primary hyperoxaluria diagnosed after kidney transplantation failure: lesson from 3 case reports and literature review. BMC Nephrol. 2019;20(1):224.CrossRef
18.
go back to reference Zhao Y, Yang Y, Zhou P, Jiang J, Chen Z, Du D, et al. Novel mutations in response to vitamin B6 in primary hyperoxaluria type 1 after only kidney transplantation: a case report. Transl Androl Urol. 2020;9(6):2848–54.CrossRef Zhao Y, Yang Y, Zhou P, Jiang J, Chen Z, Du D, et al. Novel mutations in response to vitamin B6 in primary hyperoxaluria type 1 after only kidney transplantation: a case report. Transl Androl Urol. 2020;9(6):2848–54.CrossRef
19.
go back to reference Wang Y, Yan Z, Zheng W, Xia X, Zeng W, Luo L, et al. Multi-disciplinary team on renal allograft dysfunction induced by recurrence of primary hyperoxaluria type I after renal transplantation. Organ Transplant. 2021;12(01):77–82. Wang Y, Yan Z, Zheng W, Xia X, Zeng W, Luo L, et al. Multi-disciplinary team on renal allograft dysfunction induced by recurrence of primary hyperoxaluria type I after renal transplantation. Organ Transplant. 2021;12(01):77–82.
20.
go back to reference Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A, et al. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol. 1996;155(3):839–43.CrossRef Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A, et al. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol. 1996;155(3):839–43.CrossRef
21.
go back to reference Ormanji MS, Rodrigues FG, Heilberg IP, et al. Dietary recommendations for bariatric patients to prevent kidney stone formation. Nutrients. 2020;12(5):1442. Ormanji MS, Rodrigues FG, Heilberg IP, et al. Dietary recommendations for bariatric patients to prevent kidney stone formation. Nutrients. 2020;12(5):1442.
22.
go back to reference Cochat P, Hulton SA, Acquaviva C, Danpure CJ, Daudon M, De Marchi M, et al. Primary hyperoxaluria type 1: indications for screening and guidance for diagnosis and treatment. Nephrol Dial Transplant. 2012;27(5):1729–36.CrossRef Cochat P, Hulton SA, Acquaviva C, Danpure CJ, Daudon M, De Marchi M, et al. Primary hyperoxaluria type 1: indications for screening and guidance for diagnosis and treatment. Nephrol Dial Transplant. 2012;27(5):1729–36.CrossRef
23.
go back to reference Illies F, Bonzel KE, Wingen AM, Latta K, Hoyer PF, et al. Clearance and removal of oxalate in children on intensified dialysis for primary hyperoxaluria type 1. Kidney Int. 2006;70(9):1642–8.CrossRef Illies F, Bonzel KE, Wingen AM, Latta K, Hoyer PF, et al. Clearance and removal of oxalate in children on intensified dialysis for primary hyperoxaluria type 1. Kidney Int. 2006;70(9):1642–8.CrossRef
24.
go back to reference Hoppe B. An update on primary hyperoxaluria. Nat Rev Nephrol. 2012;8(8):467–75.CrossRef Hoppe B. An update on primary hyperoxaluria. Nat Rev Nephrol. 2012;8(8):467–75.CrossRef
25.
go back to reference Horoub R, Shamsaeefar A, Dehghani M, Nikoopour H, Entezari M, Moradi A, et al. Liver transplant for primary hyperoxaluria type 1: results of sequential, combined liver and kidney, and preemptive liver transplant. Exp Clin Transplant. 2021;19(5):445–9.CrossRef Horoub R, Shamsaeefar A, Dehghani M, Nikoopour H, Entezari M, Moradi A, et al. Liver transplant for primary hyperoxaluria type 1: results of sequential, combined liver and kidney, and preemptive liver transplant. Exp Clin Transplant. 2021;19(5):445–9.CrossRef
26.
go back to reference Filippova TV, Svetlichnaya DV, Rudenko VI, Alyaev YG, Shumikhina MV, Azova MM, et al. Genetic aspects of primary hyperoxaluria: diagnostics and treatment. Urologiia. 2019;5:140–3.CrossRef Filippova TV, Svetlichnaya DV, Rudenko VI, Alyaev YG, Shumikhina MV, Azova MM, et al. Genetic aspects of primary hyperoxaluria: diagnostics and treatment. Urologiia. 2019;5:140–3.CrossRef
27.
go back to reference Dindo M, Oppici E, Dell'Orco D, Montone R, Cellini B, et al. Correlation between the molecular effects of mutations at the dimer interface of alanine-glyoxylate aminotransferase leading to primary hyperoxaluria type I and the cellular response to vitamin B6. J Inherit Metab Dis. 2018;41(2):263–75.CrossRef Dindo M, Oppici E, Dell'Orco D, Montone R, Cellini B, et al. Correlation between the molecular effects of mutations at the dimer interface of alanine-glyoxylate aminotransferase leading to primary hyperoxaluria type I and the cellular response to vitamin B6. J Inherit Metab Dis. 2018;41(2):263–75.CrossRef
28.
go back to reference Devresse A, Godefroid N, Anthonissen B, Labriola L, de Magnee C, Reding R, et al. Liver transplantation in primary hyperoxaluria type 1: we have to find an alternative! Transplantation. 2021;105(4):e46–7.CrossRef Devresse A, Godefroid N, Anthonissen B, Labriola L, de Magnee C, Reding R, et al. Liver transplantation in primary hyperoxaluria type 1: we have to find an alternative! Transplantation. 2021;105(4):e46–7.CrossRef
Metadata
Title
Primary hyperoxaluria diagnosed after kidney transplantation: a case report and literature review
Authors
Zhitao Cai
Mao Ding
Rengui Chen
Jiefu Zhu
Lian Li
Xiongfei Wu
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2021
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-021-02546-0

Other articles of this Issue 1/2021

BMC Nephrology 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.